We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
THE ROLE OF HMGB1 IN THE IMMUNE RESPONSE TO SARS-COV-2 INFECTION: FROM PATHOGENESIS TOWARDS A NEW POTENTIAL THERAPEUTIC TARGET.
- Authors
ISLAM, MUHAMMAD TOREQUL; HOSSEN, MUNNAF; KAMAZ, ZAHRAA; ZALI, ALIREZA; KUMAR, MANOJ; DOCEA, ANCA OANA; ARSENE, ANDREEA LETIȚIA; CĂLINA, DANIELA; SHARIFI-RAD, JAVAD
- Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is the most important emerging pathogen since it was discovered in late 2019, infecting millions of people worldwide. The human body's defence against this new viral respiratory infection depends on the immune response of each person with a crucial impact on the appearance of clinical signs. Therefore, it is important to identify endogenous molecules with a fundamental role in severe pulmonary inflammation associated with SARS-CoV-2 infection. The impact of high mobility group proteins (HMGBs) in the pathogenesis of coronavirus disease 2019 (COVID-19) was recently proposed. There is also recent evidence that HMGBs, particularly HMGB1-2, play important roles in the replication of viral genomes. Moreover, HMGB1-4 proteins appear to be associated with inflammatory processes in the pathogenesis of many other viral diseases and disorders, including lung disease, ischemia-reperfusion-injury, sepsis, coagulopathy, trauma, neurological disorders, and cancer. This article presents the possible roles of HMGB1 in SARS-CoV-2 replication and its involvement in the pathogenesis of clinical severe pulmonary manifestations; these data can be useful in further virologic studies and the finding of new potential therapeutic targets in COVID-19.
- Subjects
DRUG target; SARS-CoV-2; COVID-19; HIGH mobility group proteins; PATHOGENESIS
- Publication
Farmacia, 2021, Vol 69, Issue 4, p621
- ISSN
0014-8237
- Publication type
Article
- DOI
10.31925/farmacia.2021.4.1